Cresco Labs stock fell 1.09 percent as Q2 revenue rose 15 percent

Published on 10/07/2026 at 04:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cresco Labs stock posted Q2 revenue of USD 173.3 million on October 6, up 15 percent sequentially. Adjusted EBITDA reached USD 40 million, while a U.S. listing vote is set for October 30.

CL, CA22587M1068, Illustration mit AI erstellt.

Cresco Labs (ISIN CA22587M1068) was last at CAD 0.91 on the CSE on October 6, 2026 at 3:59 p.m. ET, down 1.09 percent from CAD 0.92. The company reported Q2 2026 revenue of USD 173.3 million, up 15 percent sequentially, according to Benzinga on October 6, 2026.

Revenue growth outpaced the share move

Adjusted EBITDA reached USD 40 million, an increase of 20 percent from the prior quarter, while adjusted gross profit came to USD 89 million at a 52 percent margin. Operating cash flow was USD 15 million in Q2 2026, compared with a USD 6 million use in Q1, according to Benzinga.

The operating comparison is notable because EBITDA grew faster than revenue. Retail revenue increased 18 percent sequentially to USD 121 million, while net wholesale revenue rose 7 percent to USD 52 million in the quarter.

Listing vote sets the next checkpoint

The next corporate milestone is a shareholder meeting on October 30, 2026. In its September 24, 2026 release, Cresco Labs said shareholders will vote on a share exchange creating TopCo, a possible redomicile to Delaware, and an extension of the multiple voting share sunset from one year to three years after a U.S. listing.

The proposal is designed to position the company for a potential senior U.S. exchange listing, but the release identifies shareholder, court, exchange and regulatory approvals as conditions that could affect completion. The same Q2 update also disclosed that CFO Sharon Schuller plans to step down, with a replacement search underway.

Consensus stays above the CSE quote

According to Eulerpool on September 15, 2026, 15 of 16 analysts rated Cresco Labs a Buy and one rated it a Hold. The published average price target was USD 1.75, with a median of USD 1.66, while the latest reference price on that page was USD 0.75.

The CSE quote places the stock at CAD 0.91, with a 52-week range of CAD 0.88 to CAD 3.12 as of October 6, 2026. That range puts the current quote near its yearly low, making the October vote and the conversion of Q2 growth into recurring cash generation the central valuation questions.

Cresco Labs stock stays near its yearly low

Cresco Labs stock was last at CAD 0.91 on the CSE on October 6, 2026 at 3:59 p.m. ET, with a daily change of minus 1.09 percent. Its market capitalization was CAD 322.3 million and volume was 44,499 shares on that session.